08 Otoño
Evaluation of the in vivo pilot
2
Evaluation of the in vivo pilot
3
Evaluation of the in vivo pilot
4
Evaluation of the in vivo pilot
5
Evaluation of the in vivo pilot
6
µ
Evaluation of the in vivo pilot
7
Evaluation of the in vivo pilot
8
σ
Evaluation of the in vivo pilot
9
µ
minimum
σ of ∆
µ µ
µ µ
σ
Evaluation of the in vivo pilot
10
µ
σ
Evaluation of the in vivo pilot
11
Evaluation of the in vivo pilot
12
Evaluation of the in vivo pilot
13
Evaluation of the in vivo pilot
14
Evaluation of the in vivo pilot
15
Evaluation of the in vivo pilot
16
Evaluation of the in vivo pilot
17
Evaluation of the in vivo pilot
18
σ
Evaluation of the in vivo pilot
19
σ
Evaluation of the in vivo pilot
20
Evaluation of the in vivo pilot
21
Evaluation of the in vivo pilot
22
Evaluation of the in vivo pilot
23
Evaluation of the in vivo pilot
24
Evaluation of the in vivo pilot
25
Evaluation of the in vivo pilot
26
Evaluation of the in vivo pilot
27
σ
σ
Evaluation of the in vivo pilot
28
Evaluation of the in vivo pilot
29
Evaluation of the in vivo pilot
30
Figure 1 : Singlepoint OFI device (left photography) and descirption of the measurement areas (right
picture)
.
Figure 2 : Evolution of the zero order central moment for all lesion with respect to the chronology
Evaluation of the in vivo pilot
31
Figure 3: All 9 areas averaged M0 value for the 3 main types of lesions (blue dashed line) and average
value for the central area with error bars (green square and bars) - (6 CBC, 4 MLM, 14 NEVUS)
Evaluation of the in vivo pilot
32
Figure 4: Proportion of lesions with the central area having a higher M0 value per lesion type
Evaluation of the in vivo pilot
33
Figure 5 : Démonstration of the 2D OFI in action while imaging the flow in a forearm vein
Figure 6: Delimitations of the central area (in yellow) and the surrounding areas (in white)
Evaluation of the in vivo pilot
34
Figure 7: All 210 pixels averaged M0 values for the 3 main types of lesions (blue dashed line) and
averaged value for the central area with error bars (green square and bars) - (32 CBC, 27 MLM, 105 NEVUS)
.
Evaluation of the in vivo pilot
35
Figure 81: Proportion of lesions with the central area having a higher M0 value per lesion type
Evaluation of the in vivo pilot
36
Figure 9: Images obtained with the OFI 2D for lesion MO170 (BCC) with central moment different
Evaluation of the in vivo pilot
37